tirzepatide patent expiry date Semaglutide & Considerations Ozempic's Patent Protection Starts to

These are particularly likely if you dose while fasting or have naturally lower blood sugar levels

Stopping semaglutide is more complicated

A peptide calculator can help simplify this process

According to a 2026 report from KFF, insurers are generally more likely to cover GLP-1 drugs prescribed for type 2 diabetes than those prescribed for obesity treatment

In November 2025, President Trump negotiated a deal with Eli Lilly and Novo Nordisk to reduce the price of GLP-1 drugs, resulting in a new voluntary program that allows Medicare beneficiaries to pay $50 for a months supply of GLP-1 drugs

There have also been few cases where problems such as kidney issues, inflammation of the pancreas and gall bladder disease have occurred